Feature image

What's New

M² logo Monitoring Communication – interleukin inhibitors and possible risk of pancreatitis

Medsafe has published a new monitoring communication. The aim is to encourage reporting of any cases where pancreatitis may have been associated with an interleukin inhibitor medicine.

Go to the monitoring communication